Rosas-Peralta, M. et al. 2026. Beyond Mineralocorticoid Receptor Blockade: Aldosterone Synthase Inhibition as a New Therapeutic Frontier in the Cardiovascular–Kidney–Metabolic Era-What is really new?. Annals of Clinical Hypertension. (Nov. 2026), 52–64. DOI:https://doi.org/10.29328/journal.ach.1001047.